gil m labrucherie nektar therapeutics cfo  svp  redbooks brands marketers agencies search less sell more    sign in get a free trial    contact us   gil m labrucherie cfo  svp nektar therapeutics email realtime sales trigger feed  generated by redbooks machine learning and natural language processing technology tracking  news sources to aggregate all new executives jobrole changes and news on decision makers brands and agencies in the mediamarketing industry this sales feed is for gil m labrucherie at nektar therapeutics gil m labrucherie works as cfo  svp  acting in a executive management role  nektar therapeutics is a leader in pharmaceuticals  health care products  redbooks tracks personnel changes for advertisers spending over  million annually for more executive management leads or mediamarketing prospecting automation start a free trial now recent related news  nektar therapeutics nasdaqnktr closed  above its  day average shares last traded at  which is slightly above  the stock’s  day moving average and marginally over the  day moving average of  the  day moving average was up  and the  day average went up by  trading volume for nektar therapeutics was k on thursday overall volume was down  under the stocks normal daily volume traders are feeling more bearish on shares of the company if you look at the motion in short interest the company realized a rise in short interest of  between june   and may    people in this article gil m labrucherie  howard w robin  nektar therapeutics nasdaqnktr short interest up  – currently trading up traders are feeling more bearish on nektar therapeutics lately looking at the uptick in short interest the firm experienced a rise in short interest between june   and may   of  short shares increased  over that timeframe the shortinterest ratio increased to  and the short interest percentage is  as of may  here is the rundown on market activity for nektar therapeutics nasdaqnktr sr vp john nicholson sold  shares at an average price of  on wed the th  people in this article gil m labrucherie  howard w robin  john nicholson learn more about gil m labrucherie and  key contacts   create targeted lead lists   gain insider knowledge with advanced machine  learning   realtime verified contact info enter work email please enter email address please enter valid email address learn more about gil m labrucherie and  key contacts first name  please enter first name last name  please enter last name company name  please enter company name email  phone  please enter phone number please enter  digits number what industry are you in    please select one the categories below please enter value for the industry  media sales  production  adtechmartech  sponsorship sales   agency new business   other what is your role    please select one the categories below please enter value for the role   csuite   vpmanager   sales rep   other thank you for registering for a free redbookscom trial we are processing your request and will be in touch shortly to get you started for immediate assistance please call us at   or email us at inforedbookscom home learn more free trial features ad think events thought leadership events top advertiser directory top agency directory add your agency update your agency agency showcase advertising associations creative spotlight services and suppliers about us blog contact us jobs terms  conditions privacy policy customer support   connect with us copyright   red books llc all rights reserved gil m labrucherie jr  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in gil m labrucherie jr senior vice president and chief financial officer at nektar therapeutics view full profile are you gil m labrucherie jr claim your profile   sign up for equilar atlas and view gil m labrucherie jrs full profile with equilar atlas you can identify corporate executives in gil m labrucherie jrs network and community follow changes in gil m labrucherie jrs employment and moneyinmotion connect with gil m labrucherie jr through your network of contacts gil m labrucherie jrs executive work history current senior vice president and chief financial officer nektar therapeutics past to view gil m labrucherie jrs complete executive work history sign up now education ba university of california  davis jd university of california  berkeley age      gil m labrucherie jrs biography gil m labrucherie has served as our senior vice president and chief financial officer since june  mr labrucherie served as our vice president corporate legal from october  through april  and served as our senior vice president general counsel and secretary from april  through june  when he was promoted to senior vice president and chief financial officer from october  to september  mr labrucherie was vice president of corporate development at eopen while at eopen mr labrucherie was responsible for global corporate alliances and merger and acquisitions prior to eopen he was the senior director of cor  read more gil m labrucherie has served as our senior vice president and chief financial officer since june  mr labrucherie served as our vice president corporate legal from october  through april  and served as our senior vice president general counsel and secretary from april  through june  when he was promoted to senior vice president and chief financial officer from october  to september  mr labrucherie was vice president of corporate development at eopen while at eopen mr labrucherie was responsible for global corporate alliances and merger and acquisitions prior to eopen he was the senior director of corporate development at altavista company an internet search company where he was responsible for strategic partnerships and mergers and acquisitions mr labrucherie began his career as an associate in the corporate practice of the law firm of wilson sonsini goodrich  rosati pc mr labrucherie received his jd from the berkeley law school and a ba from the university of california davis source nektar therapeutics on    sign up for equilar atlas and view gil m labrucherie jrs full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like gil m labrucherie jr more specifically youll be able to identify corporate executives in gil m labrucherie jrs network and community follow changes in gil m labrucherie jrs employment and moneyinmotion connect with gil m labrucherie jr through your network of conections view full profile   search for over  executive profiles bio example gil m labrucherie jr gil m labrucherie jrs connections  sign up now to view gil m labrucherie jrs  connections » michael a brown former chief executive officer and director symantec corporation maninder hora senior vice president pharmaceutical development and manufacturing operations nektar therapeutics dennis l winger board member accuray incorporated roy a whitfield board member nektar therapeutics ivan p gergel senior vice president drug development and chief medical officer nektar therapeutics david johnston former svp research  development nektar therapeutics robert b chess chairman of the board nektar therapeutics lutz lingnau board member nektar therapeutics john s patton former chief scientific officer nektar therapeutics irwin lerner former chairinterim presceo medarex popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla claiborne p deming chairman of the board murphy oil corporation daniel a dematteo executive chairman gamestop corp × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   gil m labrucherie jr  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in gil m labrucherie jr senior vice president and chief financial officer at nektar therapeutics view full profile are you gil m labrucherie jr claim your profile   sign up for equilar atlas and view gil m labrucherie jrs full profile with equilar atlas you can identify corporate executives in gil m labrucherie jrs network and community follow changes in gil m labrucherie jrs employment and moneyinmotion connect with gil m labrucherie jr through your network of contacts gil m labrucherie jrs executive work history current senior vice president and chief financial officer nektar therapeutics past to view gil m labrucherie jrs complete executive work history sign up now education ba university of california  davis jd university of california  berkeley age      gil m labrucherie jrs biography gil m labrucherie has served as our senior vice president and chief financial officer since june  mr labrucherie served as our vice president corporate legal from october  through april  and served as our senior vice president general counsel and secretary from april  through june  when he was promoted to senior vice president and chief financial officer from october  to september  mr labrucherie was vice president of corporate development at eopen while at eopen mr labrucherie was responsible for global corporate alliances and merger and acquisitions prior to eopen he was the senior director of cor  read more gil m labrucherie has served as our senior vice president and chief financial officer since june  mr labrucherie served as our vice president corporate legal from october  through april  and served as our senior vice president general counsel and secretary from april  through june  when he was promoted to senior vice president and chief financial officer from october  to september  mr labrucherie was vice president of corporate development at eopen while at eopen mr labrucherie was responsible for global corporate alliances and merger and acquisitions prior to eopen he was the senior director of corporate development at altavista company an internet search company where he was responsible for strategic partnerships and mergers and acquisitions mr labrucherie began his career as an associate in the corporate practice of the law firm of wilson sonsini goodrich  rosati pc mr labrucherie received his jd from the berkeley law school and a ba from the university of california davis source nektar therapeutics on    sign up for equilar atlas and view gil m labrucherie jrs full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like gil m labrucherie jr more specifically youll be able to identify corporate executives in gil m labrucherie jrs network and community follow changes in gil m labrucherie jrs employment and moneyinmotion connect with gil m labrucherie jr through your network of conections view full profile   search for over  executive profiles bio example gil m labrucherie jr gil m labrucherie jrs connections  sign up now to view gil m labrucherie jrs  connections » michael a brown former chief executive officer and director symantec corporation maninder hora senior vice president pharmaceutical development and manufacturing operations nektar therapeutics dennis l winger board member accuray incorporated roy a whitfield board member nektar therapeutics ivan p gergel senior vice president drug development and chief medical officer nektar therapeutics david johnston former svp research  development nektar therapeutics robert b chess chairman of the board nektar therapeutics lutz lingnau board member nektar therapeutics john s patton former chief scientific officer nektar therapeutics irwin lerner former chairinterim presceo medarex popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla claiborne p deming chairman of the board murphy oil corporation daniel a dematteo executive chairman gamestop corp × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   gil labrucherie  nektar therapeutics  zoominfocom   gil labrucherie   decypha sign in  welcome guest regions gcc  levant  mena  north africa gcc bahrain  kuwait  oman  qatar  saudi arabia  united arab emirates levant iraq  jordan  lebanon  palestine north africa egypt  libya  morocco  tunisia others iran  turkey  united kingdom  united states advanced search news markets companies research funds fixed income money markets commodities fx economics analysis more sign in membership customize your decypha logout welcome decypha alerts home people profiles people profile gil labrucherie profile full name gil labrucherie country biography gil m labrucherie has served as our senior vice president general counsel and secretary since april  responsible for all aspects of our legal affairs designations date designation entity entity description country  nektar therapeutics inc pharmaceuticals biotechnology  life sciences united states check all the individuals in check the list request a trial title select mr mrs ms miss dr prof first name last name job title select asset managers corporate banks investment managers wealth managers consultants  advisors legal practioners academics hedge funds private equity analysts traders equity research analysts phone company email country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe comments required fields   submit already registered login attempt was not successful please try again username email password enter characters   login forget your password by job title asset managers  corporate banks  investment managers  wealth managers  consultants  advisors  legal practitioners  academics  hedge funds  private equity analysts  traders  equity research analysts by scope equity  fixed income  funds  excel  analytical tools  markets  prices  money market  news  industry  ipos  mergers  acquisitions  commodities  economics covered countries and exchanges add your company   add yourself   terms and conditions   privacy policy   about directfn copyright  directfn all rights reserved data not available login login attempt was not successful please try again username email password enter characters forget your password back to top support  feedback ask for free trial request a trial title mr mrs ms miss dr prof first name last name email phone promo code country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe company job title select academics asset managers consultants  advisors corporate banks equity research analysts hedge funds investment managers legal practioners private equity analysts traders wealth managers comments required fields   submit contact us hello please use the below form for product support  feedback name   email  phone number   preferred contact method  email phone technical support x     slhopsdirectfnnet your account manager is   get a decypha membership to view this content get a decypha membership get the membership of decypha premium package to access more exciting features including advanced analytical tools and the pro  package pro  is designed keeping active investors in mind and offers a flexible framework to view information and do analysis the way you desire all you need to access these valuable features is to click on the get a membership button and submit your details to our sales team upgrade your membership account is not entitled to view this information please contact your account manager to upgrade your membership email  supportdecyphacom register to view this content decypha free registration register free with decypha and get access to realtime price information and many other features including technical scanner fundamental screener etc just click the registration button submit your details and get registered for free labrucherie gil m  sec form  insider trading screener  openinsider openinsider latest latest cluster buys latest insider trading all filings latest insider purchases latest insider purchases k latest officer purchases k latest ceocfo purchases k latest insider sales latest insider sales k latest officer sales k latest ceocfo sales k top top officer purchases today top officer purchases past week top officer purchases past month top insider purchases today top insider purchases past week top insider purchases past month top insider sales today top insider sales past week top insider sales past month by symbol officer purchases k today officer purchases k past week officer purchases k past month officer sales k today officer sales k past week officer sales k past month officer sales k today no optex officer sales k past week no optex officer sales k past month no optex insider purchases of penny stocks past month insider sales of penny stocks past month charts contact labrucherie gil m  sec form  insider trading screenercik   address co nektar therapeutics  mission bay boulevard south san francisco ca  general tickers insider sh price  lqdty m date filing date all dates custom latest day last  days last  week last  weeks last  month last  months last  months last  months last  year last  years last  years    trade date all dates custom latest day last  days last  week last  weeks last  month last  months last  months last  months last  year last  years last  years    filing delay n days ago transaction filing p  purchase s  sale a  grant d  sale to iss g  gift f  tax m  option ex x  option ex c  cnv deriv w  inherited no deriv multiple days traded k own chg  industry all sectors except funds agriculture forestry fish mining construction manufacturing transportation  utilities wholesale trade retail trade financial services closedend funds insider title   officer     cob     ceo     pres     coo     cfo     gc     vp   director    own   other group by filing company company totals num filings num insiders num officers traded k own chg  sort by filing date trade date ticker symbol trade value max results page clear realtime csv options alerts  results        tccntdwmms x filing date trade date ticker insider nameinsider title trade type  share price shares traded shares owned own chg value traded d ret w ret m ret m ret   nktrlabrucherie gil msvp cfos  sale dm  nktrlabrucherie gil msvp cfos  saleoe   nktrlabrucherie gil msvp cfos  sale   nktrlabrucherie gil msvp cfos  sale   nktrlabrucherie gil msvp cfos  sale d  nktrlabrucherie gil msvp gcs  saleoe d  nktrlabrucherie gil msvp gcs  saleoe d  nktrlabrucherie gil msvp gcs  saleoe d  nktrlabrucherie gil msvp gcs  saleoe d  nktrlabrucherie gil msvp gcs  saleoe d  nktrlabrucherie gil msvp gcs  saleoe d  nktrlabrucherie gil msvp gcs  saleoe d  nktrlabrucherie gil msvp gcs  saleoe d  nktrlabrucherie gil msvp gcs  saleoe realtime csv options alerts contact us aamended filing dderivative transaction in filing usually option exercise eerror detected in filing mmultiple transactions in filing earliest reported transaction date and weighted average transaction price s  salesale of securities on an exchange or to another persons  saleoesale of securities on an exchange or to another person after option exercisef  taxpayment of exercise price or tax liability using portion of securities received from the companyp  purchasepurchase of securities on an exchange or from another person return to top copyright   openinsidercom all rights reserved gil and sandra labrucherie  santa rosa  ca  company information products resources my account talk to a db advisor  business directory ca santa rosa animal specialty services boarding services horses racing and nonracing gil and sandra labrucherie g gil and sandra labrucherie claim this business  faught rd santa rosa ca  get directions   wwwfieldstonefarmbiz business info founded  incorporated annual revenue  employee count  industries boarding services horses racing and nonracing contacts gil labrucherie contact business your email address subject message send message company summary since  gil and sandra labrucherie has been providing boarding services horses racing and nonracing from santa rosa verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   g view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved nektar  company  our leadership our leadership our leadership including the management team and board of directors is made up of biotechnology and pharmaceutical industry experts who are recognized for their contributions in the discovery and development of new therapies and their success in bringing new treatments to patients and physicians howard w robin president and chief executive officer howard robin joined nektar therapeutics in january  he has more than  years of successful biopharmaceutical experience managing clinical development and commercial operations most recently mr robin served as president and chief executive officer of sirna therapeutics a clinicalstage biotechnology company pioneering rnaibased therapies for serious diseases and conditions including agerelated macular degeneration amd hepatitis c asthma respiratory syncytial virus rsv and huntingtons disease during his tenure at sirna mr robin successfully relaunched the company and created significant shareholder value that led to its acquisition by merck for  billion prior to sirna mr robin spent  years at berlex laboratories the us pharmaceutical subsidiary of the german pharmaceutical firm schering ag from  to  he served as corporate vice president and general manager of their us therapeutics division and was responsible for the development of drugs such as betaseron® interferon betab for multiple sclerosis and fludara® fludarabine phosphate for chronic lymphocytic leukemia generating annual global sales in excess of  million he also served as a member of the executive committee prior to that he was vice president of finance and business development and cfo of berlex earlier in his career mr robin was a senior associate with arthur andersen and co mr robin serves as a director of the biotechnology industry organization the worlds largest biotechnology industry trade organization and also serves as a director of baybio a nonprofit trade association serving the northern california life sciences community mr robin holds a bs in accounting and finance from fairleigh dickinson university in new jersey and serves as a member of its board of trustees close bio stephen k doberstein phd senior vice president and chief scientific officer steve doberstein joined nektar in january  as senior vice president and chief scientific officer to lead all aspects of discovery research at nektar dr doberstein brings over  years of experience in biotechnology research and development to the company prior to joining nektar dr doberstein was vice president of research at xoma where he was responsible for directing the discovery and development of their drug candidates including antibody discovery and support of clinical development through nonclinical safety translational medicine and pharmacokinetics pharmacodynamics prior to that dr doberstein served as vice president research at five prime therapeutics inc a protein and antibody discovery and development company where he built and led a high performance discovery research and process development group while at five prime he established programs resulting in multiple strategic alliances with pharmaceutical partners built a strong proprietary pipeline and moved multiple product candidates from concept to preind stages in diabetes oncology rheumatoid arthritis and osteoarthritis prior to that dr doberstein was vice president research at xencor an antibody and protein engineering and development company at xencor he was instrumental in advancing its protein platform technologies and preclinical product candidates before that he also held a number of senior positions at exelixisdr doberstein received his phd in biochemistry cell and molecular biology from the johns hopkins university school of medicine and completed his postdoctoral work at uc berkeley earlier in his career dr doberstein held a variety of engineering roles at dupont after receiving his bsche degree in chemical engineering from the university of delaware close bio ivan gergel md senior vice president drug development and chief medical officer ivan gergel joined nektar in may  as senior vice president drug development  chief medical officer to oversee the companys clinical strategy and activities including direct supervision of clinical research medical affairs regulatory affairs and drug safety and surveillance dr gergel brings over  years of pharmaceutical leadership and drug development experience to nektar with deep expertise in all aspects of the clinical and regulatory process prior to joining nektar dr gergel served as executive vice president research  development of endo pharmaceuticals and chief scientific officer where he led clinical research regulatory project management and medical affairs during his tenure with endo dr gergel was responsible for a number of late stage development programs and product approvals including bema® buprenorphine which is in phase  abusedeterrent opana® er for chronic pain and fortesta® and aveed™ for hypogonadism prior to joining endo dr gergel served as senior vice president of research and development for forest laboratories inc as the head of the clinical organization and then as the senior rd executive for the company dr gergel oversaw the successful development programs leading to the approval of numerous nces to treat a range of cns disorders and other medical conditions including celexa® for depression aerospan™ for asthma lexapro® for depression and generalized anxiety disorder namenda® for alzheimers disease combunox™ for acute pain and savella® for fibromyalgia dr gergel also led the organization through the approval and launch of bystolic® for hypertension and campral® for alcohol dependency in addition while at forest laboratories inc dr gergel led the rd team responsible for the successful inlicensing or acquisition of several new agents including turdoza™ for copd linzess® for ibs and the antiinfective teflaro® prior to forest dr gergel was a senior leader at smithkline beecham where he led the us clinical team responsible for the development and commercial support of paxil® which is approved to treat depression ocd panic disorder social phobia and generalized anxiety disorder dr gergel received his md from the royal free medical school of the university of london and an mba from the wharton school of the university of pennsylvania close bio dorian hirth senior vice president human resources and facilities operations as senior vice president human resources and facilities operations ms hirth is responsible for designing and implementing hr strategies and programs that attract develop and retain talent for a highperforming workforce ms hirths experience spans  years at biotechnology companies leading strategic and tactical aspects of human resource functions including managing issues surrounding mergers and acquisitions prior to joining nektar in  ms hirth headed the human resource programs at sirna therapeutics where she was part of the diligence team during the acquisition process by merck she was also part of the team that started sugen and transitioned it from startup through two acquisitions initially by pharmacia and then by pfizer inc in addition she served as vice president human resources and facilities at kosan biosciences and corgentechanesiva close bio maninder hora phd senior vice president pharmaceutical development and manufacturing operations maninder hora joined nektar in august  as senior vice president pharmaceutical development and manufacturing operations to lead management and oversight of nektars cmc bioanalytical and manufacturing operations worldwide dr hora has been in the biopharmaceutical industry for  years with demonstrated expertise in process analytical and pharmaceutical sciences manufacturing and quality functions for biologics vaccines small molecules and drug delivery systems he has led large teams of scientists and engineers to perform early and late stage development as well as lifecycle management cmc activities he brings to nektar the experience of registering nine drugs or vaccines products in the united states or europe dr hora most recently served as vice president of product operations  quality at facet biotech a spinoff from pdl biopharma now a part of abbott laboratories he joined pdl biopharma in  as vice president of process development and later took charge of product operations  quality from  to  dr hora served in various positions of increasing responsibility at chiron corporation now novartis with his last position being vice president of process and product development during the period  to  dr hora also worked at smith kline  french now glaxo smithkline and ayerstwyeth now pfizer prior to joining chirondr hora received his phd from the indian institute of technology in bioengineering materials in  and held a fulbright fellowship at the university of washington seattle dr hora holds twenty one us patents and has authored scores of publications and delivered numerous presentations in international forums he serves as a scientific advisor for reviva pharmaceuticals an emerging research based pharmaceutical company close bio gil m labrucherie senior vice president and chief financial officer gil m labrucherie was appointed senior vice president and chief financial officer of the company in june  mr labrucherie has held several senior leadership positions with increasing responsibility at nektar since  most recently he served as senior vice president general counsel and secretary of nektar from  to  prior to joining nektar from october  to september  mr labrucherie was vice president of corporate development at eopen inc where he was responsible for global corporate alliances and merger and acquisition activity prior to eopen he was the senior director of corporate development at altavista company an internet search company where he was responsible for merger and acquisition transactions mr labrucherie began his career as an associate in the corporate practice of the law firm of wilson sonsini goodrich  rosati and graham  james dla piper rudnickmr labrucherie received his jd from university of california boalt hall school of law where he was a member of the california law review and order of the coif and received his ba from the university of california davis close bio john nicholson senior vice president and chief operating officer john nicholson was appointed senior vice president and chief operating officer coo of the company in june  mr nicholson reports to nektars president and chief executive officer howard w robin from  to  mr nicholson was senior vice president and chief financial officer cfo previously he was senior vice president corporate development and business operations at nektar prior to joining nektar he served in a number of leadership roles at bayer schering pharma ag including vice president corporate development and treasurer of schering berlin inc president of schering berlin insurance company president of bayer pharma chemicals inc and president of schering berlin capital corporation mr nicholson also served as treasurer of berlex inc close bio jillian b thomsen senior vice president finance and chief accounting officer jillian b thomsen joined nektar in march  and was appointed chief accounting officer in april  ms thomsen has  years of financial reporting and accounting experience she currently oversees accounting financial reporting planning  analysis sarbanesoxley compliance treasury and taxprior to april  she served as vice president finance and controller of nektar before joining nektar ms thomsen was deputy controller of calpine corporation from september  to february  from december  to may  ms thomsen performed various roles with arthur andersen starting as a staff accountant and concluding as a senior manager ms thomsen holds a masters of accountancy from the university of denver and a ba in business economics from colorado college close bio carlo j di fonzo phd senior vice president drug development  regulatory affairs carlo j di fonzo leads drug development and regulatory affairs at nektar with oversight responsibilities for regulatory affairs gcpglp compliance and toxicology dr di fonzos experience includes over  years in regulatory affairs and safety roles in the pharmaceutical and biotechnology industry during his career dr di fonzo has been part of several teams that helped bring new medicines to patients including lipitor® neurontin® accupril® xigris® forteo® alimta® gemzar® zyprexa® strattera® cialis® and movantik™ prior to joining nektar in  dr di fonzo led regulatory affairs and quality compliance at eli lilly canada where he was also responsible for patentlisting strategies and product safety functions prior to joining eli lilly in november  he worked at warnerlambertparkedavis canada where he was had oversight of toxicology and safety studies as well as regulatory affairs dr di fonzo received his undergraduate degree in biologic sciences his masters degree in clinical biochemistry and his phd in clinical biochemistry and toxicology from the university of toronto canada close bio jennifer ruddock senior vice president investor relations  corporate affairs jennifer ruddock heads the investor relations and corporate affairs department at nektar which includes public affairs corporate and employee communications and public relations ms ruddocks experience spans  years in biotechnology technology and finance prior to joining nektar in  ms ruddock held leadership roles in investor relations financial communications and corporate marketing at a number of public companies including catellus development corporation acquired by prologis and tumbleweed communications acquired by axway prior to that she worked in the sales and trading department at montgomery securities acquired by bank of america a san franciscobased investment bank which specialized in high technology and healthcare sectors while at montgomery she obtained both her series  and  licenses ms ruddock began her career in medical device sales at curtin matheson scientific inc acquired by fisher scientific ms ruddock received her undergraduate degree in neuroscience from colgate university in  close bio mary tagliaferri md senior vice president clinical development mary tagliaferri provides strategic and operational leadership at nektar for clinical development drug safety and risk management as well as medical affairs and scientific writing she brings to nektar over  years of experience in pharmaceutical drug development and extensive regulatory expertise in oncology and womens health prior to joining nektar in january  she served as chief medical officer at kanglaite usa a privatelyheld biotechnology company which develops oncology drug products in multiple solid tumor settings she also served as a consultant to intermune inc acquired by rocheprior to that dr tagliaferri was a cofounder and president and chief medical officer of bionovo inc at bionovo she was responsible for all aspects of the companys clinical drug development strategy including spearheading clinical studies for all drug products overseeing global regulatory affairs leading data management and biostatistics and ensuring the proper conduct of clinical studies dr tagliaferri received the  state of california woman of the year award for her advancements of clinical research in womens health and her mentorship of women in the biotechnology field dr tagliaferri received her bachelor of science degree from cornell university and her medical degree from the university of california san francisco ucsf close bio jonathan zalevsky phd senior vice president biology  preclinical development jonathan zalevsky joined nektar in july  as vice president of biology and preclinical development to lead biological research and grow the discovery portfolio dr zalevsky brings over  years of experience spanning both large pharmaceutical and small biotechnology companies to nektar prior to joining nektar dr zalevsky was the global vice president and head of the inflammation drug discovery unit at takeda pharmaceuticals as the leading immunologist for takeda he was responsible for an immunology pipeline that spanned from early target discovery to latestage development and launched products while at takeda dr zalevskys leadership resulted in  new inds and phase  clinical starts which included both internallydiscovered and inlicensed firstinclass immunetargeting molecules prior to working at takeda dr zalevsky held a number of research and development positions at xencor inc where he was responsible for the discovery and development of xencors first four clinicalstage assets during that period he authored numerous highprofile publications on xencordiscovered drugs and wrote four inds earlier in his career dr zalevsky worked as a developmental biologist at stanford universitydr zalevsky received his phd in biochemistry from the tetrad program at the university of california at san francisco ucsf he received dual bachelor degrees in biochemistry and molecular cellular and developmental biology from the university of colorado at boulder close bio kevin brodbeck phd vice president  cmc small molecules pharmaceutical development  manufacturing kevin brodbeck joined nektar in  as vice president of pharmaceutical development at nektar dr brodbeck is responsible drug product development for biologics and small molecules process chemistry development for small molecule drug substance and process chemistry development for clinical supply manufacturing dr brodbeck has over  years of pharmaceutical and product development experience in the fields of cns pain and oncology prior to joining nektar dr brodbeck headed formulation and process sciences at powderject technologies and served as the director of product development at alza in the biopharmaceutical research  implant division while at alza dr brodbeck developed and commercialized the viadur leuprolide mg oneyear implant dr brodbeck was also the lead inventor of number of novel protein delivery technologies for sustained release and improved stability of biopharmaceutical agents dr brodbeck received his phd and ms degrees in chemical engineering from stanford and the university of illinois and his bs degree in chemical engineering from the university of california berkeley dr brodbeck is the holder of numerous patents and is published in the field of pharmaceutical formulation process sciences and drug delivery close bio michael a eldon phd fcp vice president clinical pharmacology dr eldon leads nektars clinical pharmacology department that is responsible for clinical and preclinical pharmacokinetics and adme pharmacometrics and systems biology in drug development and discovery dr eldon who joined nektar in  has over  years of experience in pharmacokinetics and clinical pharmacology in the pharmaceutical industry prior to nektar dr eldon worked at parkedavis pharmaceutical research in ann arbor mi where he participated in the development and registration of lipitor® atorvastatin neurontin® gabapentin rezulin® troglitazone lyrica® pregabalin proair® procaterol lopid® gemfibrozil loestrin® oral contraceptive estrostep® oral contraceptive procanbid® procainamide extended release fempatch® transdermal estradiol cerebyx® fosphenytoin penetrex® enoxacin zagam® sparfloxacin and nitrostat® nitroglycerin stabilized tablets while at nektar he has participated in the development and registration of movantik™naloxegol and the preclinical and clinical development of all other nektar proprietary products including nktr nktr and nktr dr eldon received his undergraduate degree in pharmacy and phd in biopharmaceutics and pharmacokinetics from the university of cincinnati he is a member of several pharmaceutical societies has authored over  scientific articles and presentations and is a fellow of the american college of clinical pharmacology close bio chulani karunatilake phd vice presidentcmc biologics pharmaceutical development  manufacturing chulani karunatilake joined nektar in  as vice president pharmaceutical development  manufacturing in this role dr karunatilake is responsible for biologics cmc and has global responsibilities for analytical bioanalytical and quality control functions dr karunatilake has over  years of experience in the biopharmaceutical industry having contributed to several successful biotechnology drug development and registration efforts at amgen chironnovartis and genentech prior to nektar dr karunatilake was director process development at amgenfremont where he was responsible for the analytical and purification development departments and led the quality by design qbd task force in the fda pilot program prior to amgen dr karunatilake was senior director responsible for analytical development and quality control functions at chironnovartis prior to chironnovartis he was at genentech where he held management roles of increasing responsibility in analytical technologies and quality control areas dr karunatilake received his phd in biochemistrychemistry from university of illinois he received his bsc honors degree in chemistry from university of colombo sri lanka close bio henk kocken phd vice president quality assurance henk kocken joined nektar in october  as vice president quality assurance dr kocken brings over  years of experience in the management of quality systems and quality assurance in the biopharmaceutical industry to nektar prior to joining nektar dr kocken served as the vp of regulatory affairs and quality for alvine pharmaceuticals prior to alvine dr kocken was vp of quality systems at vaxgen where he led the quality unit responsible for developing compliance quality assurance and quality control systems for the development manufacture and control of anthrax and smallpox vaccines before vaxgen dr kocken served in various senior quality assurance and systems roles at cotherix intermune fibrogen biorad laboratories and clontech laboratoriesprior to his career in industry dr kocken was assistant professor of molecular biology at the eindhoven university of technology in the netherlands he received his phd in chemical technology from eindhoven university of technology and his ms in molecular biology from nijmengen university in the netherlands close bio mark a wilson vice president and general counsel mark a wilson has been our vice president and general counsel since july  mr wilson has over  years in the legal field with a particular emphasis on intellectual property prior to serving as nektar’s general counsel mr wilson led nektar’s intellectual property department with oversight for the companys extensive patent portfolio including the preparation and prosecution of patent applications prior to joining nektar in  mr wilson was an associate at reed  associates a patent law firm in menlo park california where he successfully represented both startup and fortune  companies mr wilson received his jd from seton hall university school of law and his bs in pharmacy from rutgers university college of pharmacy he is registered to practice before the us patent and trademark office close bio sunny xie vice president biometrics and rd systems sunny xie leads biometrics and rd systems at nektar with oversight of biostatistics and statistical programming for clinical development mr xie brings  years of statistics and programming experience in both biotech and large pharmaceutical companies to nektar prior to joining nektar in  mr xie was senior director statistical programming at gilead sciences inc while at gilead mr xie led statistical programming group that supported all therapeutic areas including hiv liver disease oncology inflammation  respiratory and cardiovascular prior to gilead mr xie worked at shire pharmaceuticals overseeing process improvement clinical applications and support and training in clinical development operations and biometrics before shire he spent more than  years at forest laboratories as the executive director of statistical programming earlier in his career he held various roles in the biometrics groups at eli lilly  company and at pharmacia now pfizer mr xie received his masters of science degree in statistics from sam houston state university in huntsville texas and his bachelor of science degree in applied mathematics and application software design from shandong university in china close bio our storyour leadershipour board of directorsour partnerslocationscontact read the latest news join nektar and make a difference okay go back microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates amazoncom amazon music unlimited interesting finds updated daily amazon try prime digital music all departments alexa skills amazon devices amazon video amazon warehouse deals appliances apps  games arts crafts  sewing automotive parts  accessories baby beauty  personal care books cds  vinyl cell phones  accessories clothing shoes  jewelry    women    men    girls    boys    baby collectibles  fine art computers courses credit and payment cards digital music electronics gift cards grocery  gourmet food handmade health household  baby care home  business services home  kitchen industrial  scientific kindle store luggage  travel gear luxury beauty magazine subscriptions movies  tv musical instruments office products patio lawn  garden pet supplies prime exclusive prime pantry software sports  outdoors tools  home improvement toys  games vehicles video games wine go departments en   hello sign inaccount  listssign inaccount  listsorderstry primecart your amazoncomtodays dealsgift cards  registrysellhelpdisability customer support amazon music unlimited prime music cds  vinyl download store open web player mp cart settings mo for prime members nonprime price month change or cancel anytime start your day free trial mo for prime members nonprime price month change or cancel anytime start your day free trial mo for prime members nonprime price month change or cancel anytime start your day free trial any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial theres a problem loading this menu right now learn more about amazon prime get fast free shipping with amazon prime prime members enjoy free twoday shipping and exclusive access to music movies tv shows original audio series and kindle books  get started v robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates